|Bid||39.020 x 100|
|Ask||0.000 x 0|
|Day's Range||42.090 - 42.800|
|52 Week Range||36.580 - 47.100|
|PE Ratio (TTM)||N/A|
|Expense Ratio (net)||0.35%|
Health-care stocks finished dead last in the Standard & Poor's 500 as Republicans tried yet again to repeal and replace the Affordable Care Act. The Cassidy-Graham bill, named for Senator Bill Cassidy, R-La., and Lindsey Graham, R-S.C., was introduced Sept. 13 and appears to be gaining momentum. Cassidy-Graham would get rid of individual and employer mandates and subsidies and rollback Medicaid, among other things.
For 2Q17, Keytruda reported revenues of $881 million, which represents 183% growth at constant exchange rates.
Eli Lilly and Co.’s (LLY) cardiovascular franchise includes two drugs—Cialis and Effient. These drugs comprise ~15.0% of the company's total revenues.